Review Article

医学实践中的干细胞和组织工程:道德和监管政策

卷 20, 期 4, 2019

页: [388 - 398] 页: 11

弟呕挨: 10.2174/1389450119666180831095830

价格: $65

摘要

目前,干细胞研究和组织工程已成为全球合法化和受监管的干细胞治疗方案,但从科学角度来看,它们的成功尚未确定。新型干细胞疗法已经成为世界各地商业公司和医院的创新和常规临床解决方案。干细胞诊所在英国,美国,欧洲和亚洲的这种猖獗的传播反映了公众对无法治愈的疾病的益处的鼓励。然而,不断增长的干细胞治疗发展需要政府监管机构持续不断地进行监督并制定谨慎的政策,以便在出现任何不良公众关注的情况下迅速采取行动。因此,研究人员和医生必须及时掌握当前关于干细胞,组织工程设备治疗及其安全法律限制的知识。为此,干细胞科学发展,治疗方案和法律方案在这里被介绍给初学者或积极的科学家和医生。干细胞治疗简介将为初学者和实践医师提供有关工程干细胞研究概念的基本信息,并在不同的北美,欧洲和亚洲国家提供干细胞治疗联邦法规。不同国家的FDA,CDC,EU,ICMR政府政策包括有关当前法律地位,道德政策,监管监督和相关法律的信息。

关键词: 多能干细胞,干细胞医学实践,组织工程,干细胞治疗,干细胞法律状态,政府指南,监管政策。

图形摘要

[1]
Ratajczak MZ, Kucia M, Jadczyk T, et al. Pivotal role of paracrine effects in stem cell therapies in regenerative medicine: Can we translate stem cell-secreted paracrine factors and microvesicles into better therapeutic strategies? Leukemia 2012; 26(6): 1166-73.
[2]
European Commission, Community Research and Development Information Service: Available from:. http://cordis.europa.eu/home_ en.html
[3]
European Commission, International Cooperation and Development:. http://ec.europa.eu/europeaid/work/funding/beneficiaries/index.cfm?lang=en&mode=SM&type
[6]
Fortpflanzungsmedizingesetz geändert wird (Fortpflanzungsmedizingesetz- Novelle 2004 – FMedGNov 2004), Reproductive Medicine Act Amendment 2004 – FmedGNov 2004: Available from:. http:// www.ris.bka.gv.at/Dokument.wxe?Abfrage=BgblAuth& Dokumentnummer= BGBLA_ 2004_I_163 ,
[7]
‘Research on human embryonic stem research’ Opinion of the Austrian Bioethics Commission, 16 March 2009, Bunderkanzleramt Österriech, Austrian Bioethics Commission:. http://www.bka.gv.at/ site/3575/default.aspx
[8]
‘Ethical aspects of the development and use of assistive technologies’, Opinion of the Austrian Bioethics Commission, 13 July 2009, Bunderkanzleramt Österriech, Austrian Bioethics Commission:. http://www.bka.gv.at/DocView.axd?CobId=39411
[9]
‘Collecting stem cells from umbilical cord blood’, Ruling of the Bioethics Commission, 16 March 2009, Bunderkanzleramt Österriech, Austrian Bioethics..
[10]
The Health Act (Promulgated in the State Gazette, issue No. 70/10 August 2004, entered into force on 1 January 2005):. http://solicitorbulgaria.com/index.php/bulgarian-health-act-part-2
[12]
Regulation on the terms and conditions of activity of the central ethics commission under the Council of Ministers in accordance with the Law of Medicinal Products in Human Medicine (adopted 28 September 2007, SG 81/0 October 2007):.http://lex.bg/en/laws/ ldoc/2135566887
[13]
Bulgarian Centre for Bioethics:. http://www.bio-ethics.net/en/ content/mission
[14]
Act on Research on Human Embryonic Stem Cells and Related Activities and on Amendment to Some Related Acts, Zákon o výzkumu na lidských embryonálních kmenových buňkách a souvisejících činností a na Změně některých souvisejících zákonů:. http://aplikace.msmt.cz/PDF/JJHumanstemcells.pdf
[15]
Bioethical Commission of the Czech Research and Development Council:. http://www.vyzkum.cz/FrontClanek.aspx?idsekce=15908
[16]
Act on Medical Research (9.4.1999/488), Laki lääketieteellisestä tutkimuksesta (9.4.1999/488) Suomi:. http://www.finlex.fi/fi/laki/ alkup/1999/19990488
[17]
Finnish National Ethics Committee report 2006, Opinion on EU research funding on stem cells.http;//www.etene.fi/ en/ materials/opinions/2006
[18]
The Act on the Medical Use of Organs and Tissues (2.2.2001/101), Laki lääketieteellisestä käytöstä elimien ja kudoksien (2.2.2001/101). http://www.finlex.fi/fi/laki/alkup/2001/20010102
[19]
Law on Bioethics, Law n. 2004-800 of 6 August 2004 (Loi n. 2004- 800 du 6 Août 2004 relative à la bioéthique):. http://ec.europa.eu/ research/biosociety/pdf/french_law.pdf andhttp://www.legifrance. gouv.fr/affichTexte.do?cidTexte=JORFTEXT000000441469&date Texte
[21]
French ConstCouncil, 27 July 1994, 94-343-344 DC:. http:// www.conseil-constitutionnel.fr/decision/1994/94343dc.htm
[22]
Act ensuring Protection of Embryos in connection with the importation and use of human embryonic stem cells, Gesetz zur Sicherstellung des Embryonenschutzes im Zusammenhang mit Einfuhr und Verwendung menschlicher embryonaler Stammzellen Stammzellgesetz (StZG- Stem Cell Act), 14 August 2008:.http://bundesrecht.juris.de/stzg/index.html
[23]
Central Ethics Commission for Stem Cell Research [Zentrale Ethik- Kommission für Stammzellenforschung - ZES. https:// www.eurostemcell.org/regulation-stem-cell-research-germany
[25]
Law on the Transplantation of Organs, Tissues and Cells (Promulgated in the State Gazette, issue No. 83/19 September 2003, entered into force on 1 January 2004), Available from:. http://bgtransplant.bg/iat/docs/Law%20on%20transplantation.doc
[26]
Bioethical Commission of the Czech Research and Development Council, Available from:. http://www.vyzkum.cz/Front
[27]
Finnish National Ethics Committee, "Opinion on EU research funding on stem cells "The Act on the Medical Use of Organs and Tissues (2.2.2001/101), Laki lääketieteellisestä käytöstä elimien ja kudoksien (2.2.2001/101), Available from:. http://www.finlex.fi/fi/ laki/alkup/ 2001/20010102
[30]
Law 3305/2005 on Medically assisted reproduction techniques, Official Gazette of the Hellenic Republic, 27 January 2005, Νόμος 3305/2005 για την ιατρικώς υποβοηθούμενης αναπαραγωγής (ΦΕΚ Α΄17 27.1.2005) Available from:.http://www.nurs.uoa.gr/fileadmin/ nurs.uoa.gr/uploads/Nomothesia_Nosilefton/Nomoi/Nomos_3305_FEK_A__172005.pdf
[31]
Hellenic National Bioethics Commission, "Report on the use of stem cells in biomedical research and clinical medicine", Available from:. http://www.bioethics.gr/media/pdf/reports/stem_cell_report_ eng.pdf
[32]
Irish Stem Cell Research Foundation, Irish Public Policy and Human Embryonic Stem Cell Research, Irish Stem Cell Research Foundation, April 2010, Available from:. http:// www.irishstemcellfoundation.org/docs/policy.pdf
[33]
Law on Ethics of Biomedical Research No.VIII-1679 of 11 May 2000 (last amended on 15 November 2007 – No. X-1325), available Available from:. http://www3.lrs.lt/pls/inter3/dokpaieska. showdoc_ l?p_id=326057
[34]
Lithuanian Bioethics Committee (LBC), Available from:. http://bioetika.sam.lt/index.php?-381039724
[35]
Law No. 32/2006 of 26 July on medically assisted procreation [Lei no. 32/2006 Procriação medicamente assistida de 26 de Joelho], Available from:.http://www.fd.unl.pt/docentes_docs/ma/tpb_MA_ 4022.pdf
[36]
47/CNECV/05, Opinion Nº 47: ‘Opinion on Stem Cell Research’, Conselho Nacional de Ética para as Ciências da Vida (CNECV),The National Council of Ethics for the Life Sciences, Available from:. http://www.cnecv.pt/pareceres.php
[37]
Law on Biomedical Research 14/2007 of July 3, Ley 14/2007, de 3 de julio, de Investigación biomedical, Madrid: Boletín Oficial del Estado, Available from:.http://www.boe.es/boe/dias/2007/07/04/ pdfs/A28826-28848.pdf
[38]
Guarantees Commission for the Donation and Use of Human Cells and Tissues, established under the following law: Real Decreto 1527/2010, de 15 de noviembre, por el que se regulan la Comisión de Garantías para la Donación y Utilización de Células y Tejidos Humanos y el Registro de Proyectos de Investigación. Available from:. http://www.boe.es/buscar/doc.php?id=BOE-A-2010-18654
[39]
Opinion on a preliminary law proposal regulating stem cell research, 2003-05-20, Statins Medinksa -Etisk Rad, Swedish National Council of Bioethics, Available from:. http:// www.smer.se/yttranden/remissyttrande-angaende-sou-2002119-rattslig-reglering-av-stamcellsforskning/
[40]
House of Lords Select Committee on Stem Cell Research (2002), Available from:. http://www.parliament.the-stationery-office.co.uk/ pa/ld200102/ldselect/ldstem/83/8301.htm
[41]
21CFR Part 1271- Human cells, tissues, and cellular and tissue based products. Cornell University document.. https:// www.law.cornell.edu/cfr/text/21/part-1271
[42]
Human Tissue Act 2004, Available from:. http:// www.legislation.gov.uk/ukpga/2004/30/contents
[43]
Human Fertilisation and Embryology (Research Purposes) Regulations 2001:.http://www.legislation.gov.uk/uksi/2001/188/pdfs/ uksi_20010188_en.pdf
[44]
Law JX, Liau LL, Aminuddin BS, Ruszymah BH. Tissue-engineered trachea: A review. Int J Pediatr Otorhinolaryngol 2016; 91: 55-63.
[45]
Stem Cell Therapies: 4. Opportunities for Ensuring the Quality and Safety of Clinical Offerings: Summary. Board on Health Sciences Policy; Board on Life Sciences; Division on Earth and Life Studies; Institute of Medicine; National Academy of Sciences.Washington (DC): National Academies Press (US); 2014.
[46]
Yamanaka S. Induction of pluripotent stem cells from mouse fibroblasts by four transcription factors. Cell Prolif 2008; 41(Suppl. 1): S51-6.

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy